Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsLiabilities and Shareholders EquityNon-Current AssetsPayablesPrepaid AssetsRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tenax Therapeutics (TENX) Treasury Shares (2016 - 2025)

Tenax Therapeutics' Treasury Shares history spans 6 years, with the latest figure at $106.0 for Q1 2017.

  • On a quarterly basis, Treasury Shares fell 56.02% to $106.0 in Q1 2017 year-over-year; TTM through Mar 2017 was $106.0, a 56.02% decrease, with the full-year FY2016 number at $12.0, down 40.0% from a year prior.
  • Treasury Shares hit $106.0 in Q1 2017 for Tenax Therapeutics, up from $12.0 in the prior quarter.
  • Over the last five years, Treasury Shares for TENX hit a ceiling of $55537.0 in Q1 2013 and a floor of $12.0 in Q4 2016.
  • Historically, Treasury Shares has averaged $11337.5 across 5 years, with a median of $443.5 in 2016.
  • Biggest five-year swings in Treasury Shares: surged 2115.86% in 2014 and later plummeted 99.79% in 2015.
  • Tracing TENX's Treasury Shares over 5 years: stood at $10639.0 in 2013, then crashed by 97.85% to $229.0 in 2014, then crashed by 91.27% to $20.0 in 2015, then tumbled by 40.0% to $12.0 in 2016, then surged by 783.33% to $106.0 in 2017.
  • Business Quant data shows Treasury Shares for TENX at $106.0 in Q1 2017, $12.0 in Q4 2016, and $367.0 in Q3 2016.